← Back to Search

Lay Navigator Intervention for End of Life (CAREPlan Trial)

N/A
Waitlist Available
Research Sponsored by Stanford University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months after patient enrollment
Awards & highlights

CAREPlan Trial Summary

This trial is testing if a layperson can help cancer patients with advance care planning, to improve patient activation, satisfaction, quality of life, and the quality of end of life cancer care.

Eligible Conditions
  • End of Life
  • Cancer

CAREPlan Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months after patient enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months after patient enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Goals of Care Documentation
Secondary outcome measures
Emergency Department Visit using chart abstraction
Hospice using chart abstraction
Hospitalization Visit using chart abstraction
+1 more

CAREPlan Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention Group ArmExperimental Treatment2 Interventions
Patients randomized into the intervention will be assigned a lay patient navigator who will provide information regarding early advance care planning, documentation of goals of care, and coordinating home-based care. The intervention arm will also receive usual care as provided by their local oncologists.
Group II: Control Group ArmActive Control1 Intervention
The control group will receive usual care as provided by their local oncologists.

Find a Location

Who is running the clinical trial?

Stanford UniversityLead Sponsor
2,374 Previous Clinical Trials
17,332,527 Total Patients Enrolled
5 Trials studying End of Life
4,601 Patients Enrolled for End of Life

Media Library

Lay Navigator Intervention Clinical Trial Eligibility Overview. Trial Name: NCT03856463 — N/A
End of Life Research Study Groups: Control Group Arm, Intervention Group Arm
End of Life Clinical Trial 2023: Lay Navigator Intervention Highlights & Side Effects. Trial Name: NCT03856463 — N/A
Lay Navigator Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT03856463 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still the possibility to join this experiment?

"According to clinicaltrials.gov this medical experiment has concluded its recruitment period, which began on October 25th 2019 and closed with the last edit made on November 4th 2022. While not currently taking partakers, there are 570 other trials actively recruiting for participants at this time."

Answered by AI

What aims does this trial aim to accomplish?

"This clinical trial will track its primary outcome, Goals of Care Documentation over a 6 month period following patient enrollment. Additional metrics that the study is measuring include: Advance Directive Documentation which entails abstracting electronic medical records for each patient at 6 months; Patient Activation via a validated survey using the Patient Activation Measure taken at both baseline and after six months; and Emergency Department Visits documented with the Health Care Use Assessment survey inquiring about ED usage in the past half year."

Answered by AI
~68 spots leftby Mar 2025